112 results on '"Cozzi, Diletta"'
Search Results
102. Atypical HRCT manifestations of pulmonary sarcoidosis
- Author
-
Cozzi, Diletta, primary, Bargagli, Elena, additional, Calabrò, Alessandro Giuseppe, additional, Torricelli, Elena, additional, Giannelli, Federico, additional, Cavigli, Edoardo, additional, and Miele, Vittorio, additional
- Published
- 2017
- Full Text
- View/download PDF
103. Advanced Magnetic Resonance Imaging (MRI) Techniques: Technical Principles and Applications in Nanomedicine
- Author
-
Federico Bruno, Vincenza Granata, Flavia Cobianchi Bellisari, Ferruccio Sgalambro, Emanuele Tommasino, Pierpaolo Palumbo, Francesco Arrigoni, Diletta Cozzi, Francesca Grassi, Maria Chiara Brunese, Silvia Pradella, Maria Luisa Mangoni di S. Stefano, Carmen Cutolo, Ernesto Di Cesare, Alessandra Splendiani, Andrea Giovagnoni, Vittorio Miele, Roberto Grassi, Carlo Masciocchi, Antonio Barile, Bruno, Federico, Granata, Vincenza, Cobianchi Bellisari, Flavia, Sgalambro, Ferruccio, Tommasino, Emanuele, Palumbo, Pierpaolo, Arrigoni, Francesco, Cozzi, Diletta, Grassi, Francesca, Brunese, Maria Chiara, Pradella, Silvia, di S Stefano, Maria Luisa Mangoni, Cutolo, Carmen, Di Cesare, Ernesto, Splendiani, Alessandra, Giovagnoni, Andrea, Miele, Vittorio, Grassi, Roberto, Masciocchi, Carlo, and Barile, Antonio
- Subjects
Cancer Research ,Oncology ,diffusion weighted imaging ,dynamic contrast enhancement ,magnetic resonance imaging ,nanoparticles ,contrast media ,nanomedicine - Abstract
Simple Summary Magnetic Resonance Imaging (MRI) is a consolidated imaging tool for the multiparametric assessment of tissues in various pathologies from degenerative and inflammatory diseases to cancer. In recent years, the continuous technological evolution of the equipment has led to the development of sequences that provide not only anatomical but also functional and metabolic information. In addition, there is a growing and emerging field of research in clinical applications using MRI to exploit the diagnostic and therapeutic capabilities of nanocompounds. This review illustrates the application of the most advanced magnetic resonance techniques in the field of nanomedicine. In the last decades, nanotechnology has been used in a wide range of biomedical applications, both diagnostic and therapeutic. In this scenario, imaging techniques represent a fundamental tool to obtain information about the properties of nanoconstructs and their interactions with the biological environment in preclinical and clinical settings. This paper reviews the state of the art of the application of magnetic resonance imaging in the field of nanomedicine, as well as the use of nanoparticles as diagnostic and therapeutic tools, especially in cancer, including the characteristics that hinder the use of nanoparticles in clinical practice.
- Published
- 2022
104. A Multicenter Study of Post-COVID-19 Interstitial Lung Syndrome
- Author
-
Valentina Luzzi, Tiberio Oggionni, Emanuela Barisione, Elena Bargagli, Martina Bonifazi, Stefano Gasparini, Marco Confalonieri, Raffaele Scala, Catherine Klersy, Federica Meloni, Adele Torricella, Federico Lavorini, Elisabetta Rosi, Leonardo Gori, Sonia Bambina, Martina Marinato, Giulia Biadene, Diletta Cozzi, Edoardo Cavigli, Vittorio Miele, Sara Piciucchi, Nicola Sverzellati, Silvia Puglisi, Venerino Poletti, Claudia Ravaglia, Sara Tomassetti, Ciro Battiloro, Martina Bonifazi, Ernesto Crisafulli, Giuseppe Failla, Paola Faverio, Claudio Micheletto, Lara Pisani, Carlo Roberto Sacco, Silvia Tognella, Alessandro Zanforlin, Luzzi, Valentina, Oggionni, Tiberio, Barisione, Emanuela, Bargagli, Elena, Bonifazi, Martina, Gasparini, Stefano, Confalonieri, Marco, Scala, Raffaele, Klersy, Catherine, Meloni, Federica, Torricella, Adele, Lavorini, Federico, Rosi, Elisabetta, Gori, Leonardo, Bambina, Sonia, Marinato, Martina, Biadene, Giulia, Cozzi, Diletta, Cavigli, Edoardo, Miele, Vittorio, Piciucchi, Sara, Sverzellati, Nicola, Puglisi, Silvia, Poletti, Venerino, Ravaglia, Claudia, and Tomassetti, Sara
- Subjects
interstitial lung disease ,pulmonary fibrosis ,post-COVID sequelae ,COVID-19 ,Long-COVID - Abstract
Introduction: Available data indicate that a large minority of patients with COVID-19 develop ARDS, and pulmonary fibrosis is a recognized sequela of ARDS. However, the long-term pulmo- nary consequences of COVID-19 remain speculative. Objects: The aim of this study is to evaluate risk factors, preva- lence and characteristics of POST-COVID-19 interstitial lung changes, with the unique opportunity to evaluate radiologic and pathologic correlations using HRCT and transbronchial lung cryobiopsy specimens. Methods: Here we present the preliminary data on HRCT fea- tures of POST-COVID-19 ILD. Data were collected at the time of the first interim analysis (28/11/2020) of the PCOILS trial: a pro- spective, multicenter national study involving 12 Italian centers (Fig 1). We collected data of consecutively hospitalized patients at baseline and then at 6 (+/-1) months after hospital discharge. HRCT changes at 6 months involving more than 5% of the total lung volume were considered significant. Patients with significant HRCT changes will undergo BAL and/or cryobiopsy and a subse- quent follow-up with HRCT and lung function evaluation at 12(+/-1) and 18 (+/-1) months. Results: At the time of the present interim analysis, 524 patients from 9 centers were enrolled (enrollment is still ongoing and will end on January 31st, 2021). Median age was 67 years (range 18-87), 330 were males (62.9%). HRCT changes were detected in 333 par- ticipants (63.5%), and in 219 (41.7%) were considered significant. 118 cases (22.5%) showed fibrotic changes including the following HRCT patterns: 7 (1.3%) probable UIP, 45 (8.5%) NSIP (with or without OP), 38 (7.2%) indeterminate, 28 (5.3%) fibrotic consoli- dations. Among the remaining 101 (19.2%) non fibrotic cases the radiologists described: 11 (2%) NSIP-OP, 15 (2.8%) indeterminate, 67 (12.7%) pure ground glass, 8 (1.5%) consolidations all suspected for lung cancer. Conclusions: This preliminary analysis confirms that after COVID-19 infection a large minority of patients develops intersti- tial lung changes mostly with NSIPOP, indeterminate features or ground glass. The hypothesis that post-COVID-19 interstitial changes and interstitial lung diseases may share common risk fac- tors, pathogenetic mechanisms and disease behaviour warrants further evaluations.
- Published
- 2021
105. The Azygos Esophageal Recess Is Not to Be Missed in Screening Lung Cancer With LDCT.
- Author
-
Mascalchi M, Cavigli E, Picozzi G, Cozzi D, De Luca GR, and Diciotti S
- Abstract
Purpose: Lesion overlooking and late diagnostic workup can compromise the efficacy of low-dose CT (LDCT) screening of lung cancer (LC), implying more advanced and less curable disease stages. We hypothesized that the azygos esophageal recess (AER) of the right lower lobe (RLL) might be an area prone to lesion overlooking in LC screening., Materials and Methods: Two radiologists reviewed the LDCT examinations of all the screen-detected incident LCs observed in the active arm of 2 randomized clinical trials: ITALUNG and national lung screening trial. Those in the AER were compared with those in the remainder of the RLL for possible differences in diagnostic lag according to the Lung-RADS 1.1 recommendations, size, stage, and mortality., Results: Six (11.7%) of 51 screen-detected incident LCs of the RLL were located in the AER. The diagnostic lag time was significantly longer (P=0.046) in the AER LC (mean 14±9 mo) than in the LC in the remaining RLL (mean 7.3±1 mo). Size and stage at diagnosis were not significantly different. All 6 subjects with LC in the AER and 16 (35.5%) of 45 subjects with LC in the remaining RLL (P=0.004) died of LC after a median follow-up of 12 years., Conclusion: Our retrospective study indicates that AER might represent a lung region of the RLL prone to have early LC overlooked due to detection or interpretation errors with possible detrimental consequences for the subject undergoing LC screening., Competing Interests: The authors declare no conflict of interest., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
106. Pulmonary vasculitis in Behçet's disease: reference atlas computed tomography pulmonary angiography (CTPA) findings and risk assessment-management proposal.
- Author
-
Emad Y, Ragab Y, Cozzi D, Ibrahim O, Abdelrahman W, Abdelali M, Kechida M, Hassanin M, Tharwat S, Salah S, Elshaarawy N, Frikha F, Hassanein S, Young P, Pankl S, Barman B, Abou-Zeid A, and Rasker J
- Abstract
Background and Aim: Pulmonary artery aneurysms (PAAs) are the most well-defined type of pulmonary vascular complication in Behçet's disease (BD).The aim of this study is to analyze which CT pulmonary angiography (CTPA) signs are associated with serious morbidity and mortality., Methods: The study included 42 BD patients with pulmonary vascular complications. All patients' medical records were reviewed retrospectively in terms of demographics, disease characteristics, laboratory investigations, pulmonary manifestations, arterial and/or venous thrombosis and CTPA vascular and parenchymal findings., Results: Deep venous thrombosis was observed in 31(73.8%) patients, arterial thrombosis in 13(31%), peripheral arterial aneurysms in 12(286%), haemoptysis in 38 (90.5%), and fatal haemoptysis in 8(19 %) patients. CTPA revealed: in situ thrombosis in 14(33.3%) patients, true stable PAAs in 13(31), true unstable PAAs in 11(26.2%), stable pulmonary artery pseudoaneurysms (PAPs) in 7(16.7%), unstable PAPs in 17(40.5%), the latter were associated with perianeurysmal leaking in 26(61.9%) and bronchial indentation in 19(45.2%).In regression analysis, fatal outcomes were associated with age in years (p=0.035), arterial thrombosis (p=0.025), peripheral arterial aneurysms (p=0.010), intracardiac thrombosis (p=0.026) and positively associated with haemoptysis severity (p<0.001)., Conclusion: Peripheral arterial thrombosis and/or aneurysms, intracardiac thrombosis and haemoptysis severity are predictor of fatal outcomes in BD pulmonary vasculitis. PAPs with perianeurysmal alveolar haemorrhage and/or bronchial indentation are serious CTPA signs that require prompt identification and aggressive treatment. PAPs are a more serious aneurysmal pattern than true PAAs because they are a contained rupture of a PA branch in the context of pulmonary vasculitis.
- Published
- 2023
- Full Text
- View/download PDF
107. Vascular tree-in-bud sign in Pulmonary Tumour Thrombotic Microangiopathy (PTTM): CT findings for a difficult radiological early antemortem diagnosis.
- Author
-
Cozzi D, Zantonelli G, Bindi A, Cavigli E, Moroni C, Pieralli F, Fattorini C, Miele V, and Bartolucci M
- Abstract
.
- Published
- 2023
- Full Text
- View/download PDF
108. Hepatic tumors: pitfall in diagnostic imaging.
- Author
-
Grazzini G, Cozzi D, Flammia F, Grassi R, Agostini A, Belfiore MP, Borgheresi A, Mazzei MA, Floridi C, Carrafiello G, Giovagnoni A, Pradella S, and Miele V
- Subjects
- Diagnosis, Differential, Humans, Magnetic Resonance Imaging, Carcinoma, Hepatocellular diagnostic imaging, Focal Nodular Hyperplasia diagnostic imaging, Liver Neoplasms diagnostic imaging
- Abstract
On computed tomography (CT) and magnetic resonance imaging (MRI), hepatocellular tumors are characterized based on typical imaging findings. However, hepatocellular adenoma, focal nodular hyperplasia, and hepatocellular carcinoma can show uncommon appearances at CT and MRI, which may lead to diagnostic challenges. When assessing focal hepatic lesions, radiologists need to be aware of these atypical imaging findings to avoid misdiagnoses that can alter the management plan. The purpose of this review is to illustrate a variety of pitfalls and atypical features of hepatocellular tumors that can lead to misinterpretations providing specific clues to the correct diagnoses.
- Published
- 2020
- Full Text
- View/download PDF
109. Masses in right side of the heart: spectrum of imaging findings.
- Author
-
Pradella S, Grazzini G, Letteriello M, De Amicis C, Grassi R, Maggialetti N, Carbone M, Palumbo P, Carotti M, Di Cesare E, Giovagnoni A, Cozzi D, and Miele V
- Subjects
- Echocardiography, Humans, Magnetic Resonance Imaging, Heart Neoplasms diagnostic imaging
- Abstract
Primary heart tumors are rare, benign tumors represent the majority of these. If a cardiac mass is found, the probability that it is a metastasis or a so-called "pseudo-mass" is extremely higher than a primary tumor. The detection of a heart mass during a transthoracic echocardiography (TE) is often unexpected. The TE assessment can be difficult, particularly if the mass is located at the level of the right chambers. Cardiac Computed Tomography (CCT) can be useful in anatomical evaluation and Cardiac Magnetic Resonance (CMR) for masses characterization as well. We provide an overview of right cardiac masses and their imaging futures.
- Published
- 2020
- Full Text
- View/download PDF
110. Radiological diagnosis of Coronavirus Disease 2019 (COVID-19): a Practical Guide.
- Author
-
Floridi C, Fogante M, Agostini A, Borgheresi A, Cellina M, Natella R, Bruno F, Cozzi D, Maggialetti N, Palumbo P, Miele V, Carotti M, and Giovagnoni A
- Subjects
- COVID-19, COVID-19 Testing, Clinical Laboratory Techniques, Coronavirus Infections epidemiology, Humans, Pneumonia, Viral epidemiology, Reproducibility of Results, SARS-CoV-2, Betacoronavirus, Coronavirus Infections diagnosis, Diagnostic Imaging standards, Pandemics, Pneumonia, Viral diagnosis, Practice Guidelines as Topic, Radiography standards
- Abstract
Novel beta-coronavirus (2019-nCoV) is the cause of Coronavirus disease-19 (COVID-19), and on March 12th 2020, the World Health Organization defined COVID-19 as a controllable pandemic. Currently, the 2019 novel coronavirus (SARS-CoV-2) can be identified by virus isolation or viral nucleic acid detection; however, false negatives associated with the nucleic acid detection provide a clinical challenge. Imaging examination has become the indispensable means not only in the early detection and diagnosis but also in monitoring the clinical course, evaluating the disease severity, and may be presented as an important warning signal preceding the negative RT-PCR test results. Different radiological modalities can be used in different disease settings. Radiology Departments must be nimble in implementing operational changes to ensure continued radiology services and protect patients and staff health.
- Published
- 2020
- Full Text
- View/download PDF
111. Internal hernias: a difficult diagnostic challenge. Review of CT signs and clinical findings.
- Author
-
Lanzetta MM, Masserelli A, Addeo G, Cozzi D, Maggialetti N, Danti G, Bartolini L, Pradella S, Giovagnoni A, and Miele V
- Subjects
- Diagnosis, Differential, Hernia, Abdominal complications, Humans, Intestinal Obstruction diagnosis, Hernia, Abdominal diagnosis, Intestinal Obstruction etiology, Multidetector Computed Tomography methods
- Abstract
Although internal hernias are uncommon, they must be beared in mind in the differential diagnosis in cases of intestinal obstruction, especially in patients with no history of previous surgery or trauma. Because of the high possibility of strangulation and ischemia of the affected loops, internal hernias represent a potentially life-threatening condition and surgical emergency that needs to be quickly recognized and managed promptly. Imaging plays a leading role in the diagnosis and in particular multidetector computed tomography (MDCT), with its thin-section and high-resolution multiplanar reformatted (MPR) images, represents the first line image technique in these patients. The purpose of the present paper is to illustrate the characteristic anatomic location, the clinical findings and the CT appearance associated with main types of internal hernia, including paraduodenal, foramen of Winslow, pericecal, sigmoid-mesocolon- and trans-mesenteric- related, transomental, supravesical and pelvic hernias.
- Published
- 2019
- Full Text
- View/download PDF
112. Relationship between diagnostic imaging features and prognostic outcomes in gastrointestinal stromal tumors (GIST).
- Author
-
Danti G, Addeo G, Cozzi D, Maggialetti N, Lanzetta MM, Frezzetti G, Masserelli A, Pradella S, Giovagnoni A, and Miele V
- Subjects
- Diagnosis, Differential, Humans, Tomography, X-Ray Computed methods, Diagnostic Imaging methods, Gastrointestinal Neoplasms diagnosis, Gastrointestinal Stromal Tumors diagnosis, Neoplasm Staging methods
- Abstract
Gastrointestinal stromal tumors (GISTs), the most frequent mesenchymal neoplasms of the gastrointestinal tract, are a relatively recently described entity. GISTs can occur across any age but are more common in patients older than 50 years. GISTs most commonly are in the stomach (60-70%), followed by the small intestine (20%-30%); they also rarely occur in the abdominal cavity, such as in the mesentery, the omentum and the retroperitoneum. Contrast-enhanced multi-detector computed tomography (MDCT) is the most largely used imaging modality for the localization, characterization and staging of GISTs. All patterns of enhancement on contrast-enhanced MDCT can be seen with GISTs, including hypoenhancing, isoenhancing, and hyperenhancing neoplasms. A lot of prognostication systems have been proposed for the risk stratification of GISTs. This review outlines the relationship between different diagnostic imaging features and prognostic outcomes in GISTs.
- Published
- 2019
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.